111 related articles for article (PubMed ID: 38744089)
1. Novel angiogenesis inhibitors with superoxide anion radical amplification effect: Surmounting the Achilles' heels of angiogenesis inhibitors and photosensitizers.
Wang K; Liu J; Hai P; Zhang W; Shan Y; Zhang J
Eur J Med Chem; 2024 Jun; 272():116495. PubMed ID: 38744089
[TBL] [Abstract][Full Text] [Related]
2. Near-Infrared Light-Initiated Molecular Superoxide Radical Generator: Rejuvenating Photodynamic Therapy against Hypoxic Tumors.
Li M; Xia J; Tian R; Wang J; Fan J; Du J; Long S; Song X; Foley JW; Peng X
J Am Chem Soc; 2018 Nov; 140(44):14851-14859. PubMed ID: 30362735
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Targeting H
Jung E; Lee J; Lee Y; Seon S; Park M; Song C; Lee D
ACS Appl Bio Mater; 2021 May; 4(5):4450-4461. PubMed ID: 35006857
[TBL] [Abstract][Full Text] [Related]
4. Novel dual-mode antitumor chlorin-based derivatives as potent photosensitizers and histone deacetylase inhibitors for photodynamic therapy and chemotherapy.
Zhang XJ; Liu MH; Luo YS; Han GY; Ma ZQ; Huang F; Wang Y; Miao ZY; Zhang WN; Sheng CQ; Yao JZ
Eur J Med Chem; 2021 May; 217():113363. PubMed ID: 33744687
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel thiophene-3-carboxamide derivatives as potential VEGFR-2 inhibitors with anti-angiogenic properties.
Li T; Wang J; Feng L; Zhou Q; Xie Q; Shen Y; Ji R; Liu X; Wang Y; Hu C
Bioorg Chem; 2024 Jun; 147():107358. PubMed ID: 38626490
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of efficient heavy-atom-free photosensitizers for photodynamic therapy of cancer.
Nguyen VN; Park SJ; Qi S; Ha J; Heo S; Yim Y; Baek G; Lim CS; Lee DJ; Kim HM; Yoon J
Chem Commun (Camb); 2020 Sep; 56(77):11489-11492. PubMed ID: 32857074
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors.
Yao Y; Huang T; Wang Y; Wang L; Feng S; Cheng W; Yang L; Duan Y
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):652-665. PubMed ID: 35109719
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-Targeting Selenophene-Modified BODIPY-Based Photosensitizers for the Treatment of Hypoxic Cancer Cells.
Karaman O; Almammadov T; Emre Gedik M; Gunaydin G; Kolemen S; Gunbas G
ChemMedChem; 2019 Nov; 14(22):1879-1886. PubMed ID: 31663667
[TBL] [Abstract][Full Text] [Related]
9. Novel 3,6-bis(imidazolidine)acridines as effective photosensitizers for photodynamic therapy.
Cižeková L; Grolmusová A; Ipóthová Z; Barbieriková Z; Brezová V; Hunáková L; Imrich J; Janovec L; Dovinová I; Paulíková H
Bioorg Med Chem; 2014 Sep; 22(17):4684-93. PubMed ID: 25096820
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel anti-angiogenesis agents. Part 7: Multitarget inhibitors of VEGFR-2, TIE-2 and EphB4.
Li C; Shan Y; Sun Y; Si R; Liang L; Pan X; Wang B; Zhang J
Eur J Med Chem; 2017 Dec; 141():506-518. PubMed ID: 29102175
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel Chlorin e6-curcumin conjugates as photosensitizers for photodynamic therapy against pancreatic carcinoma.
Jalde SS; Chauhan AK; Lee JH; Chaturvedi PK; Park JS; Kim YW
Eur J Med Chem; 2018 Mar; 147():66-76. PubMed ID: 29421571
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel anti-angiogenesis agents. Part 8: Diaryl thiourea bearing 1H-indazole-3-amine as multi-target RTKs inhibitors.
Sun Y; Shan Y; Li C; Si R; Pan X; Wang B; Zhang J
Eur J Med Chem; 2017 Dec; 141():373-385. PubMed ID: 29032031
[TBL] [Abstract][Full Text] [Related]
13. Exploration of carbamide derived pyrimidine-thioindole conjugates as potential VEGFR-2 inhibitors with anti-angiogenesis effect.
Sana S; Reddy VG; Bhandari S; Reddy TS; Tokala R; Sakla AP; Bhargava SK; Shankaraiah N
Eur J Med Chem; 2020 Aug; 200():112457. PubMed ID: 32422489
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities.
Su Y; Li R; Ning X; Lin Z; Zhao X; Zhou J; Liu J; Jin Y; Yin Y
Eur J Med Chem; 2019 Sep; 177():32-46. PubMed ID: 31129452
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic treatment of melanoma cells using aza-dipyrromethenes as photosensitizers.
Castro KADF; Costa LD; Guieu S; Biazzotto JC; da Neves MGPMS; Faustino MAF; da Silva RS; Tomé AC
Photochem Photobiol Sci; 2020 Jul; 19(7):885-891. PubMed ID: 32662457
[TBL] [Abstract][Full Text] [Related]
16. Aminosquaraines as potential photodynamic agents: Synthesis and evaluation of in vitro cytotoxicity.
Magalhães ÁF; Graça VC; Calhelha RC; Ferreira ICFR; Santos PF
Bioorg Med Chem Lett; 2017 Sep; 27(18):4467-4470. PubMed ID: 28807437
[TBL] [Abstract][Full Text] [Related]
17. A cyanine-derivative photosensitizer with enhanced photostability for mitochondria-targeted photodynamic therapy.
Zhao X; Yang Y; Yu Y; Guo S; Wang W; Zhu S
Chem Commun (Camb); 2019 Nov; 55(90):13542-13545. PubMed ID: 31647067
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure-activity relationships and biological evaluation of barbigerone analogues as anti-proliferative and anti-angiogenesis agents.
Wang G; Wang F; Cao D; Liu Y; Zhang R; Ye H; Li X; He L; Yang Z; Ma L; Peng A; Xiang M; Wei Y; Chen L
Bioorg Med Chem Lett; 2014 Jul; 24(14):3158-63. PubMed ID: 24863745
[TBL] [Abstract][Full Text] [Related]
19. Rational design of type I photosensitizers based on Ru(ii) complexes for effective photodynamic therapy under hypoxia.
Liu X; Li G; Xie M; Guo S; Zhao W; Li F; Liu S; Zhao Q
Dalton Trans; 2020 Aug; 49(32):11192-11200. PubMed ID: 32748922
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel tubulin/HDAC dual-targeting inhibitors with strong antitumor and antiangiogenic potency.
Wang Y; Sun M; Wang Y; Qin J; Zhang Y; Pang Y; Yao Y; Yang H; Duan Y
Eur J Med Chem; 2021 Dec; 225():113790. PubMed ID: 34454126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
